Previous reports by us and others had shown that FOXC1 expression could accurately identify patients with the basal-like breast cancer (BLBC) molecular subtype, the most aggressive subtype of breast cancer (38, 41, 42, 66, 128–131). This evidence concerns the gene FOXC1 and breast cancer.